Research map: Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis
Back to the article
Papers in this map
- mTOR Signaling in Growth Control and Disease · Mathieu Laplante · 2012 · 8686 citations · Cited by this paper
- Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study · 2026 · Related
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
- Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial · 2026 · Related
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial · Hertzel C. Gerstein · 2019 · 3179 citations · Cited by this paper
- Machine learning‐based prediction model for adverse pregnancy outcomes in women with gestational diabetes mellitus · 2026 · Related
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α · Sibylle Jäger · 2007 · 2497 citations · Cited by this paper
- Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub‐analysis of Hokkaido‐ TZP study data · 2026 · Related
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes · Mansoor Husain · 2019 · 2009 citations · Cited by this paper
- Response to: Methodological concerns on the predictive performance evaluation of anthropometric indices · 2026 · Related
- Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis · Robert C. Wirka · 2019 · 937 citations · Cited by this paper
- Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India · 2026 · Related
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody · Charles Pyke · 2014 · 870 citations · Cited by this paper
- Real‐world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium‐glucose cotransporter‐2 inhibitor therapy · 2026 · Related
- Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action · John R. Ussher · 2023 · 566 citations · Cited by this paper
- Improved prognosis prediction of all‐cause mortality and cardiovascular events by combined assessment of both ankle‐brachial index and brachial‐ankle pulse wave velocity in individuals with diabetes: The Kyushu prevention study for atherosclerosis, a prospective, multicenter survey · 2026 · Related
- The impact of insulin resistance on the kidney and vasculature · Ferruh Artunç · 2016 · 481 citations · Cited by this paper
- The miR ‐145‐5p/ NRF2 / SLC7A11 axis regulates ferroptosis‐mediated renal tubular epithelial cell injury in diabetic nephropathy · 2026 · Related
- The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis · Julian J. Lum · 2007 · 433 citations · Cited by this paper
- USP30 inhibits wound healing in diabetic foot ulcers by promoting TRAF6 ‐induced ferroptosis and angiogenesis inhibition · 2026 · Related
- Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis · Gabriel F. Alencar · 2020 · 420 citations · Cited by this paper
- Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension · Johanna Helmstädter · 2019 · 274 citations · Cited by this paper
- Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis · Mandy O. J. Grootaert · 2015 · 269 citations · Cited by this paper
- Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells · Battsetseg Batchuluun · 2013 · 160 citations · Cited by this paper
- GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms · Manfredi Rizzo · 2018 · 151 citations · Cited by this paper
- Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice · Teruo Jojima · 2017 · 107 citations · Cited by this paper
- Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways · Lili Shi · 2015 · 90 citations · Cited by this paper
- Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis · Charles W. Thomas · 2022 · 54 citations · Cited by this paper
- Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration · Dongming Zhou · 2020 · 51 citations · Cited by this paper
- Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia · Kaixiang Cao · 2023 · 43 citations · Cited by this paper
- Bioenergetic profile of human coronary artery smooth muscle cells and effect of metabolic intervention · Mingming Yang · 2017 · 37 citations · Cited by this paper
- Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms · Masakazu Koshibu · 2019 · 28 citations · Cited by this paper
- High Glucose Levels Promote Switch to Synthetic Vascular Smooth Muscle Cells via Lactate/GPR81 · Jing Yang · 2024 · 28 citations · Cited by this paper
- Metformin Directly Binds to MMP-9 to Improve Plaque Stability · Xianda Chen · 2023 · 16 citations · Cited by this paper
Source: OpenAlex (CC0)